HBC June-July 2020 News Bulletin

Friday, July 31, 2020

 

Rick DobrowskyHBC’s New Acting Associate Director of Research

Dr. Rick Dobrowsky recently assumed the role of HBC’s Acting Associate Director of Research.  He is a professor of pharmacology & toxicology and has been a member of the HBC internal advisory committee for several years.  We would like to thank him for stepping in. 

 

Biomedical Sciences Symposium - Survey

Due to COVID-19, the Biomedial Sciences Symposium was not held in April.  The student leaders in charge of the symposium are working hard to have the symposium take place virtually sometime in October.  In the meantime, the committee set up a survey site to determine how many individuals would be interested in presenting a virtual poster.  Please take time to send this information to your research group so they can respond by the August 24th deadline.

 

J.R. & Inez Jay Fund Awards

Inez Jay awardeeWe received seven proposals this year and three, rather than two proposals, were awarded.   Congratulations to Michael Hageman, distinguished professor of pharmaceutical chemistry, Frank Schoenen, associate research professor of the HBC, and Jingxin Wang, assistant professor of medicinal chemistry whose proposals were selected by the J.R. and Inez Jay Fund Research Award committee.  More information on the projects can be found in the KU news release published in June.  New applications will be accepted again in March of 2021.  We would like to thank everyone who submitted a J.R. & Inez Jay Fund proposal application for consideration. 

 

Equipment Award Competition winners

Rotor In the spring, a Beckman Coulter SW 41 Ti Swinging-Bucket Rotor Package was offered to HBC participants as part of an award competition.   Congratulations to Drs. Yoshiaki Azuma and Dan Dixon, both from molecular biosciences, who applied for the rotor and agreed to share its use.

 

HBC Office - REMINDER

Although the on-site HBC office remains closed (the HBC stockroom is open during normal business hours), we are still available to assist you remotely.  Our contact information is:

Pre- Award

Donna Burruss

785-864-3718

dburruss@ku.edu

Mickie Gillispie

785-864-2570

mgillisp@ku.edu

Angela Loch

785-864-8015

aloch@ku.edu

Post-Award

Matt Stevens

785-864-5549

mstevens@ku.edu

Sr. Principal Analyst

Nicole Suchy

785-864-3572

nsuchy@ku.edu

Research Support Services Manager

André Faucher

785-864-3751

dagon1@ku.edu

Associate Director of Finance and Operations

Paula Hinman

785-864-0908

phinman@ku.edu

Acting Associate Director of Research

Rick Dobrowsky

785-864-3531

dobrowsky@ku.edu

Interim Director

John Stobaugh

785-864-3996

stobaugh@ku.edu



Grant Submission Deadlines

October 2, 2020
NIH deadline for the Maximizing Investigators' Research Award (R35) for Early Stage Investigators.

October 5, 2020
NIH standard deadline for Research Grants and Cooperative Agreements (R01 and U01)– new submissions.

October 12, 2020
NIH standard deadline for Research Career Development (K series) – new submissions.

October 16, 2020
NIH standard deadline for Other Research Grants and Cooperative Agreements (R03, R21, R33, R21/R33, R34, R36, UH2, UH3, UH2/UH3) – new submissions.

Recent Awards

Meredith Hartley, Assistant Professor, Department of Chemistry, was awarded $50,000 by the American Thyroid Association for her project entitled “Thyroid hormone signaling during remyelination.”

Jennifer Robinson, Assistant Professor, Department Chemical and Petroleum Engineering, was awarded $50,000 by the KU Medical Center Research Institute for her project entitled: “Deciphering Sex Differences in Adolescent Knee Meniscal Injury and Regeneration” and  $50,000 by the Howard Hughes Medical Institute for her project entitled: “Promoting Temporomandibular Joint Fibrochondrogenesis through the use of an Estrogen Receptor Alpha Selective Agonist to Treat Osteoarthritis.”

Jingxin Wang, Assistant Professor, Department of Medicinal Chemistry, was awarded $50,000 by Bionexus KC for his project entitled “Small Molecule *Oligonucleotide Conjugate for the Treatment of Spinal Muscular Atrophy (SMA) with Improved Specificity.”

Liang Xu, Professor, Department of Molecular Biosciences, was awarded $50,000 by the University of Utah Health for his project entitled: “Novel therapeutic strategy for renal fibrosis by targeting RNA-binding protein HuR targeting.”

One of 34 U.S. public institutions in the prestigious Association of American Universities
44 nationally ranked graduate programs.
—U.S. News & World Report
Top 50 nationwide for size of library collection.
—ALA
5th nationwide for service to veterans —"Best for Vets: Colleges," Military Times
KU Today